These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31292931)

  • 1. Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia.
    Kawarada O; Hozawa K; Zen K; Huang HL; Kim SH; Choi D; Park K; Kato K; Kato T; Tsubakimoto Y; Ichihashi S; Fujimura N; Higashimori A; Sato T; Yan BP; Pang SY; Wongwanit C; Leong YP; Chua B; George RK; Chen IC; Lee JK; Hsu CH; Pua U; Iwata Y; Miki K; Okada K; Obara H
    Cardiovasc Interv Ther; 2020 Jan; 35(1):52-61. PubMed ID: 31292931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of isolated femoropopliteal in-stent restenosis.
    Qato K; Conway AM; Mondry L; Giangola G; Carroccio A
    J Vasc Surg; 2018 Sep; 68(3):807-810. PubMed ID: 30144908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced treatment of acute femoropopliteal bypass graft occlusion with Fogarty catheter guidance.
    Albayrak G; Aykut K; Guzeloglu M; Gulcu A; Hazan E
    Vascular; 2014 Aug; 22(4):262-6. PubMed ID: 23929429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to compare results from open with endovascular procedures?
    Bosiers M; Deloose K; Callaert J; Peeters P; Wauters J
    J Cardiovasc Surg (Torino); 2020 Apr; 61(2):196-199. PubMed ID: 29745216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endovascular approach for in-stent restenosis in femoropopliteal disease.
    Cannavale A; Tsetis D; Krokidis M
    Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):391-401. PubMed ID: 25761905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LumenRECON Guidewire: Pilot Study of a Novel, Nonimaging Technology for Accurate Vessel Sizing and Delivery of Therapy in Femoropopliteal Disease.
    Nair PK; Carr JG; Bigelow B; Bhatt DL; Berwick ZC; Adams G
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005333. PubMed ID: 29311285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
    Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H
    J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
    Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
    J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease.
    Zen K; Takahara M; Iida O; Soga Y; Kawasaki D; Nanto S; Yokoi H; Matoba S;
    J Vasc Surg; 2017 Mar; 65(3):720-725. PubMed ID: 28073668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duplex criteria for in-stent restenosis in the superficial femoral artery.
    Kawarada O; Higashimori A; Noguchi M; Waratani N; Yoshida M; Fujihara M; Yokoi Y; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):E199-205. PubMed ID: 22639187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
    Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
    J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB; Morrissey NJ;
    J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of duplex-detected stenosis after femoropopliteal endovascular therapy suggests questionable clinical utility of routine duplex surveillance.
    Bui TD; Mills JL; Ihnat DM; Gruessner AC; Goshima KR; Hughes JD
    J Vasc Surg; 2012 Feb; 55(2):346-52. PubMed ID: 21975061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis.
    Armstrong EJ; Thiruvoipati T; Tanganyika K; Singh GD; Laird JR
    J Endovasc Ther; 2015 Aug; 22(4):506-13. PubMed ID: 26130385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and narrative synthesis of surveillance practices after endovascular intervention for lower limb peripheral arterial disease.
    Wong KHF; Zucker BE; Wardle BG; Coughlin PA; Chaplin K; Cheng HY; Hinchliffe RJ; Twine CP; Ambler GK
    J Vasc Surg; 2022 Jan; 75(1):372-380.e15. PubMed ID: 34506892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Cilostazol Administration on Femoropopliteal In-Stent Restenosis.
    Tomoi Y; Soga Y; Iida O; Fujihara M; Ando K
    J Endovasc Ther; 2017 Oct; 24(5):640-646. PubMed ID: 28675951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anterolateral retrograde access to the distal popliteal artery and to the tibioperoneal trunk for recanalization of femoropopliteal chronic total occlusions.
    Silvestro M; Palena LM; Manzi M; Gómez-Jabalera E; Vishwanath D; Casini A; Ferraresi R
    J Vasc Surg; 2018 Dec; 68(6):1824-1832. PubMed ID: 30126786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining criteria for predicting stenosis with ultrasound duplex after endovascular intervention in infrainguinal lesions.
    Shrikhande GV; Graham AR; Aparajita R; Gallagher KA; Morrissey NJ; McKinsey JF; Dayal R
    Ann Vasc Surg; 2011 May; 25(4):454-60. PubMed ID: 21549912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of endografts to create an endoluminal femoropopliteal bypass after failed above-knee femoropopliteal open bypass surgery.
    Lensvelt MM; Wikkeling OR; Van Oostayen JA; Roukema JG; Zeebregts CJ; Reijnen MM
    Vasc Endovascular Surg; 2012 May; 46(4):338-41. PubMed ID: 22504512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Clinical Outcomes between Endovascular Therapy with Self-Expandable Nitinol Stent and Femoral-Popliteal Bypass for Trans-Atlantic Inter-Society Consensus II C and D Femoropopliteal Lesions.
    Okuno S; Iida O; Iida T; Takahara M; Yamaoka T; Kitano I; Asai M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Mano T
    Ann Vasc Surg; 2019 May; 57():137-143. PubMed ID: 30500627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.